Metabolic Disposition of Osimertinib in Rats, Dogs, and Humans: Insights Into a Drug Designed to Bind Covalently to a Cysteine Residue of Epidermal Growth Factor Receptor
Drug Metabolism and Disposition - United States
doi 10.1124/dmd.115.069203
Full Text
Open PDFAbstract
Available in full text
Date
May 25, 2016
Authors
Publisher
American Society for Pharmacology & Experimental Therapeutics (ASPET)